Idris - Biosis Group Berhad2

Embed Size (px)

Citation preview

  • 8/9/2019 Idris - Biosis Group Berhad2

    1/9

    BIOSIS GROUP BERHAD2

    Business profle

    Biosis Group Berhad is engaged in investment holding and the provision of

    management services. The Company operates in four segments: Personal

    and health care products, which is engaged in the manufacturing, marketing,

    trading and distribution of personal care products and health care products

    Pharmaceutical products, which is engaged in the manufacturing, marketing,

    trading and distribution of pharmaceutical products !irect selling, which is

    engaged in direct selling and marketing of health and food supplements and

    personal care products, and "thers include investment holding and inactive

    companies. #ts subsidiaries include Biosis Cosmeceuticals $dn. Bhd., Biosis

    %arketing $dn. Bhd., Biosis Pharmaceuticals $dn. Bhd. Biosis %arketing &'()

    Pte. *td. and !+'air $hop &%) $dn. Bhd.

    Biosis Group Berhad, &Biosis) formerly 'iCity Bioscience Group Berhad,

    manufactures, markets and distributes personal care, health care, and

    pharmaceutical products. The company+s o-ering includes pharmaceuticals,

    medical devices and life science products, body care products, hair care

    products, oral care products, foot care products and skin care and cosmetics.

    The company also entered into direct retail marketing of personal care

    products through its subsidiary !+'air $hop &%) $dn. Bhd. The company is

    headuartered at Penang, %alaysia.

    The company+s strategy is to enhance its o-ering portfolio and entering into

    new market by introducing new products, enhancing its e/isting products.

    The company disposed Biosis Pharmaceuticals $dn. Bhd. as the subsidiary

    was not able to ful0ll certain conditions.

  • 8/9/2019 Idris - Biosis Group Berhad2

    2/9

    Biosis Group Berhad : Practice Note !

    Pursuant to paragraph 1.23 and paragraph 4.5&e) of Practice 6ote 57

    &8P6578) the %ain %arket *isting 9euirements &8%%*98) of Bursa %alaysia

    $ecurities Berhad &8Bursa $ecurities8) where the auditors have e/pressed an

    emphasis of matter on B#"$#$+ ability to continue as a going concern in the

    latest audited 0nancial statements, the Board of !irectors of B#"$#$ wishes

    to announce that B#"$#$ is considered as a P657 Company.

    The P657 criteria triggered as a result of the Company+s latest unaudited

    accounts for the 0nancial year ended 5 %arch 425 that was announced on

    5 %ay 425 where the Company+s shareholders+ euity on a consolidated

    basis is ;2< or less of the issued and paidup capital &=the >irst

    ?nnouncement@).

    OB"IGA#IONS O$ #HE %O&PAN' PURSUAN# #O PN!

    Pursuant to paragraph 1.23&) of the %%*9, B#"$#$ is reuired to comply

    with the following:

    &i) ?nnounce within months from the >irst ?nnouncement, on whether the

    regularisation plan will result in a signi0cant change in the business direction

    or policy of the Company

    &ii) Aithin 54 months from the date of the >irst ?nnouncement:

  • 8/9/2019 Idris - Biosis Group Berhad2

    3/9

    &a) submit a regulariation plan to the $ecurities Commission &8$C8) if the

    plan will result in a signi0cant change in the business direction or policy of

    the Company

    &b) submit a regulariation plan to Bursa $ecurities if the plan will not resultin a signi0cant change in business direction or policy of the Company, and

    obtain Bursa $ecurities approval to implement the plan.

    &iii) #mplement the regulariation plan within the time frame stipulated by the

    $C or Bursa $ecurities, as the case may be

    &iv) ?nnounce the status of its regulariation plan and the number of monthsthe end of the relevant time frames referred in paragraphs ;.5 and ;.4 of

    P657, as may be applicable, on a monthly basis until further notice from

    Bursa $ecurities

    &v) ?nnounce its compliance or noncompliance with a particular obligation

    imposed pursuant to P657, on immediate basis

    &vi) ?nnounce the details of the regulariation plan &89euisite

    ?nnouncement8) and suDcient information to demonstrate that the

    Company is able to comply with all the reuirements set out in paragraph .5

    of P657 after implementation of the regulariation plan. The 9euisite

    ?nnouncement must be made by the Companys Principal ?dviser and

    &vii) Ahere the Company fails to regularie its condition, it will announce the

    dates of suspension and delisting of its listed securities immediately uponnoti0cation of suspension and delisting by Bursa $ecurities.

    . C"6$EFE6CE$ "> 6"6C"%P*#?6CE "> A#T' T'E "B*#G?T#"6$

  • 8/9/2019 Idris - Biosis Group Berhad2

    4/9

    #n the event the Company fails to comply with the obligations to regularise

    its condition, all its listed securities will be suspended from trading on the

    ne/t market day after 0ve &;) market days from the date of noti0cation of

    suspension and delisting by Bursa $ecurities and delisting procedures shall

    be taken against the Company, subHect to the Companys right to appeal

    against delisting.

    3. $T?T$ "> 9EG*?9#$?T#"6 P*?6

    The Company intends to formulate a regularisation plan to address its P657status and this will be announced to Bursa $ecurities in due course.

    This announcement is dated 26 June 2013.

    Balance sheet

    n millions of MYR(except for per share items)Annual dataInterim data

    Fiscal data as of Mar 31 2014 2014 2013 2012

    ASSETS

    ash And !hort "erm In#estments 0$4% 0$31 0$3&

    "otal Recei#a'les et 3$34 1% 1*

    "otal In#entor+ 2$2& %$,- -$,*

    .repaid expenses // 0$3& 0$-0

    ther current assets total // 13 0$&3

    Total current assets 6.08 34 27

    .ropert+ plant euipment net 2% 2& 4-

    oodill net // // //

    Intan5i'les net // 3$0, 3$22

  • 8/9/2019 Idris - Biosis Group Berhad2

    5/9

    Fiscal data as of Mar 31 2014 2014 2013 2012

    6on5 term in#estments 2$%3 2$%, 2$4,

    ote recei#a'le / lon5 term // 3$4& ,$&&

    ther lon5 term assets // // //

    Total assets 34 73 87

    LIABILITIES

    Accounts pa+a'le 4$0, 3$-2 4$&3

    Accrued expenses // 2$,% 2$24

    otes pa+a'le7short/term de't 33 -$23 1%

    urrent portion lon5/term de't7capital leases // 1, 11

    ther current lia'ilities total 21 1% ,$33

    Total current liabilities 57 45 39

    "otal lon5 term de't 1$00 12 14

    "otal de't 34 3% 40

    Deerre! inco"e ta# 0.$8 $.05 $.53

    Minorit+ interest 0$*0 (0$&3) 0$1%

    ther lia'ilities total 0$34 0$%1 0$,*

    Total liabilities 60 57 56

    S%A&E%'LDE&S E()IT*

    ommon stoc8 %3 %3 %3

    Additional paid/in capital 0 0 0

    Retained earnin5s (accumulated deficit) (-*) (40) (24)

    "reasur+ stoc8 / common // // //

    9nreali:ed 5ain (loss) // 2$2* 2$2*

    ther euit+ total (0$12) (0$12) (0$0%)

    Total e+uit, -26 $5 3$

    Total liabilities / sareol!ers1 e+uit, 34 73 87

    "otal common shares outstandin5 10% 10% 10%

    "reasur+ shares / common primar+ issue 0 0 0

  • 8/9/2019 Idris - Biosis Group Berhad2

    6/9

    %ash $lo(

    In millions of MYR(except for per share items)Annual dataInterim data

    Fiscal data as of Mar 31 2014 2014 2013 2012

    'E&ATI'S

    et income (40) (1-) (22)

    ;epreciation7depletion 2$*4 4$&0 *$10

    on/ash items 30 %$*, *$03

    ash taxes paid supplemental (0$02) 0$12 0$00

    ash interest paid supplemental 0$3* 1$,% 2$4-

    han5es in or8in5 capital 1$,0 11 ,$&,

    Total cas ro" oerations -5.55 4.53 $.06

    IESTI

    aital e#en!itures -0.0$ -0.26 -0.54

    ther in#estin5 and cash flo items total 12 (0$0&) 3$&-

    Total cas ro" inestin $2 -0.35 3.43

    :IAI

    Financin5 cash flo items 0$%4 0$23 (0$%2)

    Total cas !ii!en!s ai! ;; ;; ;;

    Issuance (retirement) of stoc8 net // 0 2$%0

    Issuance (retirement) of de't net (%$*0) (3$00) (&$-%)

    Total cas ro" inancin -5.26 -2.77 -7.77

    ET %AE I AS%

    Forei5n exchan5e effects 0$00 0$00 0$01

    et cane in cas $.54 $.42 -3.27

    et cash/'e5in 'alance7reser#ed for future use (3$24) (4$,,) (1$3&)

    et cash/end 'alance7reser#ed for future use (1$-0) (3$24) (4$,,)

  • 8/9/2019 Idris - Biosis Group Berhad2

    7/9

    Fiscal data as of Mar 31 2014 2014 2013 2012

    S)LE

  • 8/9/2019 Idris - Biosis Group Berhad2

    8/9

    Fiscal data as of Mar 31 2014 2014 2013 2012

    ES &E'ILIATI'

  • 8/9/2019 Idris - Biosis Group Berhad2

    9/9

    "in)s*re+erence

    http:IImarkets.ft.comIresearchI%arketsITearsheetsI>inancialsJsKB#"$#$:(*$

    http://markets.ft.com/research/Markets/Tearsheets/Financials?s=BIOSIS:KLShttp://markets.ft.com/research/Markets/Tearsheets/Financials?s=BIOSIS:KLS